查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1842404

美國人工器官和仿生學市場：市場規模、佔有率、趨勢分析（按產品和技術分類）、細分市場預測（2025-2033 年）

U.S. Artificial Organs And Bionics Market Size, Share & Trends Analysis Report By Product (Artificial Organs, Bionic), By Technology (Mechanical, Electronic) And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 60 Pages | 商品交期: 2-10個工作天內

價格

美國人工器官和仿生市場概覽

據估計，美國人造器官和仿生學市場在 2024 年的價值為 153.5 億美元，預計到 2033 年將達到 301.1 億美元，2025 年至 2033 年的複合年成長率為 7.7%。

市場成長的促進因素是器官移植數量的增加和等待捐贈器官人數的增加。

根據美國人力資源與服務管理局的報告，2023年美國全國器官移植等待名單上的人數超過10.4萬人。目前，平均每10分鐘就有一人被列入等待名單，這凸顯了為滿足這一未被滿足的需求而日益成長的人工醫療設備需求。這些設備涵蓋了旨在恢復器官功能或完全取代衰竭器官的各種裝置。美國國立衛生研究院（NIH）下屬的國家醫療圖像與生物工程研究所（NIBIB）積極支持這些技術的研發，以幫助人們過著更健康、更獨立的生活。

美國政府透過大量的研究經費，在促進美國人工器官和仿生產業創新方面發揮關鍵作用。美國國立衛生研究院（NIH）透過包括國家神經病變與中風研究所（NINDS）在內的多個機構，資助下一代義肢的研究，這些假體可以透過電腦介面恢復患者的運動和感覺功能。

美國人工器官與仿生市場細分

該報告預測了2021年至2033年各國的收入成長情況，並分析了各細分市場的最新產業趨勢。報告按產品和技術對美國的人工器官和仿生學市場進行了細分：

  • 按產品分類的展望：收入（十億美元，2021-2033 年）
  • 人工器官
    • 腎
    • 心
    • 肝
    • 肺
    • 胰臟
  • 仿生學
    • 人工電子耳
    • 外骨骼
    • 仿生邊緣
    • 腦仿生學
    • 視覺仿生學
  • 技術展望：收入（十億美元，2021-2033 年）
  • 機械的
  • 電子的

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章美國人工器官與仿生市場：促進因素、趨勢與範圍

  • 市場關聯性展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國人工器官與仿生學市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析
    • 美國人工器官與仿生學市場：產品線分析

第4章：美國人工器官與仿生產品市場：估算與趨勢分析

  • 產品儀錶板
  • 美國人工器官與仿生產品市場：變化分析
  • 美國人工器官及仿生產品市場規模及趨勢分析（2021-2033）
  • 人工器官
  • 仿生學

第5章美國人工器官與仿生市場：依技術分類的估算與趨勢分析

  • 技術儀錶板
  • 美國人工器官與仿生市場：依技術分類的變化分析
  • 美國人工器官及仿生技術市場規模及趨勢分析（2021-2033）
  • 機械的
  • 電子的

第6章 競爭情勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商概況
    • 主要企業熱力圖分析（2024 年）
  • 公司簡介
    • ABIOMED
    • Berlin Heart
    • SynCardia Systems, LLC
    • BiVACOR Inc.
    • Cochlear Ltd.
    • Ekso Bionics
    • Edwards Lifesciences Corporation
    • Boston Scientific Corporation
    • Jarvik Heart, Inc
    • Medtronic
Product Code: GVR-4-68040-758-2

U.S. Artificial Organs And Bionics Market Summary

The U.S. artificial organs and bionics market size was estimated at USD 15.35 billion in 2024 and is projected to reach USD 30.11 billion by 2033, growing at a CAGR of 7.7% from 2025 to 2033. The market growth is attributed to the increasing number of transplants and the rising number of people waiting for donors.

In 2023, as reported by the Human Resource and Services Administration, the national transplant waiting list in the U.S. exceeded 104,000 individuals. Currently, a new name is placed on the waiting list every ten minutes, underscoring the increasing need for artificial medical devices to address unmet demand. This includes various devices designed to restore function or fully replace failed organs. The National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health (NIH), actively supports the development of these technologies to help people live healthier, more independent lives.

The U.S. government plays a key role in fostering innovation in the U.S. artificial organs and bionic industry through significant funding for research. The NIH, through its various institutes such as the National Institute of Neurological Disorders and Stroke (NINDS), has funded research into next-generation neural prosthetics that can restore movement and sensation by using a computerized interface.

U.S. Artificial Organs And Bionic Market Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. artificial organs and bionic market report based on product and technology:

  • Product Outlook (Revenue, USD Billion, 2021 - 2033)
  • Artificial Organs
    • Kidney
    • Heart
    • Liver
    • Lungs
    • Pancreas
  • Bionic
    • Cochlear Implant
    • Exoskeleton
    • Bionic Limbs
    • Brain Bionic
    • Vision Bionic
  • Technology Outlook (Revenue, USD Billion, 2021 - 2033)
  • Mechanical
  • Electronic

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product
    • 2.2.2. Technology
  • 2.3. Competitive Insights

Chapter 3. U.S. Artificial Organs and Bionic Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Artificial Organs and Bionic Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. U.S. Artificial Organs and Bionic Market: Pipeline Analysis

Chapter 4. U.S. Artificial Organs and Bionic Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. U.S. Artificial Organs and Bionic Market: Product Movement Analysis
  • 4.3. U.S. Artificial Organs and Bionic Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Billion)
  • 4.4. Artificial Organs
    • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.4.1.1. Kidney
        • 4.4.1.1.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.4.1.2. Heart
        • 4.4.1.2.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.4.1.3. Liver
        • 4.4.1.3.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.4.1.4. Lungs
        • 4.4.1.4.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.4.1.5. Pancreas
        • 4.4.1.5.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 4.5. Bionics
    • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.5.1.1. Cochlear Implant
        • 4.5.1.1.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.5.1.2. Exoskeleton
        • 4.5.1.2.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.5.1.3. Bionic Limbs
        • 4.5.1.3.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.5.1.4. Brain Bionic
        • 4.5.1.4.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
      • 4.5.1.5. Vision Bionic
        • 4.5.1.5.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)

Chapter 5. U.S. Artificial Organs and Bionic Market: Technology Estimates & Trend Analysis

  • 5.1. Technology Segment Dashboard
  • 5.2. U.S. Artificial Organs and Bionic Market: Technology Movement Analysis
  • 5.3. U.S. Artificial Organs and Bionic Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Billion)
  • 5.4. Mechanical
    • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 5.5. Electronic
    • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. Key company heat map analysis, 2024
  • 6.4. Company Profiles
    • 6.4.1. ABIOMED
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. Berlin Heart
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. SynCardia Systems, LLC
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. BiVACOR Inc.
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Cochlear Ltd.
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. Ekso Bionics
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. Edwards Lifesciences Corporation
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. Boston Scientific Corporation
      • 6.4.8.1. Company overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives
    • 6.4.9. Jarvik Heart, Inc
      • 6.4.9.1. Company overview
      • 6.4.9.2. Financial performance
      • 6.4.9.3. Product benchmarking
      • 6.4.9.4. Strategic initiatives
    • 6.4.10. Medtronic
      • 6.4.10.1. Company overview
      • 6.4.10.2. Financial performance
      • 6.4.10.3. Product benchmarking
      • 6.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 U.S. Artificial Organs and Bionic Market, 2021 - 2033 (USD Billion)
  • Table 3 U.S. Artificial Organs and Bionic Market, by Product, 2021 - 2033 (USD Billion)
  • Table 4 U.S. Artificial Organs and Bionic Market, by Technology, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Information Procurement
  • Fig. 7 Market Formulation and Validation
  • Fig. 8 Data Validating & Publishing
  • Fig. 9 Market Segmentation & Scope
  • Fig. 10 U.S. Artificial Organs and Bionic Market Snapshot
  • Fig. 11 Product Segment Snapshot
  • Fig. 12 Technology Segment Snapshot
  • Fig. 13 Competitive Landscape Snapshot
  • Fig. 14 Parent market outlook
  • Fig. 15 U.S. Artificial Organs and Bionic Market Value, 2024 (USD Billion)
  • Fig. 16 U.S. Artificial Organs and Bionic Market - Value Chain Analysis
  • Fig. 17 U.S. Artificial Organs and Bionic Market - Market Dynamics
  • Fig. 18 U.S. Artificial Organs and Bionic Market - PORTER's Analysis
  • Fig. 19 U.S. Artificial Organs and Bionic Market - PESTEL Analysis
  • Fig. 20 U.S. Artificial Organs and Bionic Market Estimates & Forecasts, By Product: Key Takeaways
  • Fig. 21 U.S. Artificial Organs and Bionic Market Share, By Product, 2024 & 2033
  • Fig. 22 Artificial organ Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 23 Kidney Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 24 Heart Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 25 Liver Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 26 Lungs Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 27 Pancreas Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 28 Bionics Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 29 Cochlear Implant Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 30 Exoskeleton Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 31 Bionic Limbs Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 32 Brain Bionic Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 33 Vision Bionic Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 34 U.S. Artificial Organs and Bionic Market Estimates & Forecasts, By Technology: Key Takeaways
  • Fig. 35 U.S. Artificial Organs and Bionic Market Share, By Technology, 2024 & 2033
  • Fig. 36 Mechanical Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 37 Electronic Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
  • Fig. 38 Key Company Categorization
  • Fig. 39 Company Market Positioning
  • Fig. 40 Strategy Mapping